The effects of P2X7 receptor antagonists on the formation and function of human osteoclasts in vitro
- 21 April 2010
- journal article
- research article
- Published by Springer Nature in Purinergic Signalling
- Vol. 6 (3) , 307-315
Abstract
The P2X7 receptor (P2X7R) has been implicated in the process of multinucleation and cell fusion. We have previously demonstrated that blockade of P2X7Rs on osteoclast precursors using a blocking antibody inhibited multinucleated osteoclast formation in vitro, but that P2X7R KO mice maintain the ability to form multinucleated osteoclasts. This apparent contradiction of the role the P2X7R plays in multinucleation has prompted us to examine the effect of the most commonly used and recently available P2X7R antagonists on osteoclast formation and function. When added to recombinant RANKL and M-CSF human blood monocytes cultures, all but one compound, decreased the formation and function of multinucleated TRAP-positive osteoclasts in a concentration-dependent manner. These data provide further evidence for the role of the P2X7R in the formation of functional human multinucleated osteoclasts and highlight the importance of selection of antagonists for use in long-term experiments.Keywords
This publication has 41 references indexed in Scilit:
- Mechanism of action of species‐selective P2X7receptor antagonistsBritish Journal of Pharmacology, 2009
- Discovery of P2X7 receptor‐selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain statesBritish Journal of Pharmacology, 2007
- P2 receptors in macrophage fusion and osteoclast formationPurinergic Signalling, 2007
- Characterization of a selective and potent antagonist of human P2X7receptors, AZ11645373British Journal of Pharmacology, 2006
- Osteoblast responses to nucleotides increase during differentiationBone, 2006
- Effects of antagonists at the human recombinant P2X7 receptorBritish Journal of Pharmacology, 1998
- Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell CulturesBiochemical and Biophysical Research Communications, 1998
- The isoquinoline derivative KN‐62 a potent antagonist of the P2Z‐receptor of human lymphocytesBritish Journal of Pharmacology, 1997
- The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell deathImmunology Today, 1995
- Characterization of MCSF-induced proliferation and subsequent osteoclast formation in murine marrow cultureJournal of Bone and Mineral Research, 1995